31 August - 04 September 2019, Paris - France

Session Details

Hot Line Session 5
Tue 03 Sep 11:00 - 12:30 European Society of Cardiology - Other Late-Breaking Science, Mobile App - Ask a Question Paris - Main Auditorium
Chairpersons: Cecilia LINDE (Stockholm, Sweden), Martin LANDRAY (Oxford, United Kingdom of Great Britain & Northern Ireland), Davide CAPODANNO (Catania, Italy)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
11:005056CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY studyEmmanuel SORBETS (Paris, France)
11:125057Discussant review - CLARIFYDavid HASDAI (Petah-Tikva, Israel)
11:155058Questions from the audience and discussion 
11:185059SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registryErik BJOERKLUND (Moelndal, Sweden)
11:305060Discussant review - SWEDEHEARTVolkmar FALK (Berlin, Germany)
11:335061Questions from the audience and discussion 
11:365065 ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.Benedikt SCHRAGE (Hamburg, Germany)
11:485066Discussant review - ICD use in HFGerhard HINDRICKS (Leipzig, Germany)
11:515067Questions from the audience and discussion 
11:545062PURE - Contrasting patterns of cardiovascular disease, cancers and related mortality between high- versus low-middle income countries in 21 countriesDarryl LEONG (Hamilton, Canada)
12:065069PURE - Impact of modifiable risk factors on cardiovascular disease and mortalitySalim YUSUF (Hamilton, Canada)
12:185063Discussant review - PURERichard PETO (Oxford, United Kingdom of Great Britain & Northern Ireland)
12:215071Questions from the audience and discussion